Search
+
    SEARCHED FOR:

    EQUITY ISSUE

    Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details

    Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories reserved for NII and retail investors were subscribed the most at 13 times and 3.43 times, respectively.

    Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details

    Bansal Wire's IPO has been nearly 4 times oversubscribed on its second day, fueled by robust demand from non-institutional and retail investors. The IPO, conducted through the book-building method, reserves 50% for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional investors.

    Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue?

    Bansal Wire IPO: Bansal Wire's IPO offers 2.19 crore shares, closing on July 5. Analysts recommend high-risk investors consider the IPO at a P/E ratio of 41.41x. The company plans to use funds for debt repayment, with a price band of Rs 243-256 per share.

    Bansal Wire IPO offers exposure to domestic manufacturing opportunity

    Bansal Wire Industries plans to raise Rs 745 crore through an IPO to reduce debt and meet working capital needs. The company doubled its installed capacity with a Rs 500 crore investment, expecting full benefits this fiscal year. Additionally, the IPO will reduce long-term debt by two-thirds, leading to lower interest expenses. Bansal Wire Industries' EBITDA margin expanded to 6% in FY24, with RoE and RoCE above industry averages.

    Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue

    Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.

    Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival

    Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds raised as fresh issues in 2024 were to either finance capital assets or retire existing debt obtained to build capacities, according to IPO documents.

    The Economic Times
    BACK TO TOP
    Advertisement